{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:08:29Z","timestamp":1779401309702,"version":"3.53.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Granulocyte colony-stimulating factors (G-CSFs) are used in treating chemotherapy-induced neutropenia or in healthy stem cell donors before collection since they mobilize hematopoietic stem cells from the bone marrow into the peripheral blood. Reported side effects of these drugs include bone pain, fatigue, and, rarely, splenic rupture. However, G-CSFs were not previously associated with isolated hyperbilirubinemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We describe the case of a previously healthy 42-year-old female who presented to the emergency department with fever and chills. Initial laboratory investigations revealed pancytopenia along with normal liver, renal, and bilirubin levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>A peripheral smear showed an elevated blast cell count, and subsequent bone marrow cytology and flow cytometry confirmed the diagnosis of acute myelogenous leukemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was started on induction chemotherapy and subsequently developed febrile neutropenia, for which G-CSF was initiated to promote neutrophil recovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Following G-CSF initiation, the patient demonstrated a progressive rise in total bilirubin, while liver enzymes (alanine aminotransferase, aspartate aminotransferase, \u03b3-glutamyl transpeptidase) and other markers of liver function remained within normal limits. Extensive evaluation for alternative causes of hyperbilirubinemia was unremarkable, so given the temporal association and lack of other identifiable etiologies, G-CSF-induced isolated hyperbilirubinemia was suspected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case highlights a potential and previously unreported adverse effect of G-CSF. Clinicians should be aware of this possible association, particularly in patients undergoing treatment for hematologic malignancies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000044637","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:02:37Z","timestamp":1758574957000},"page":"e44637","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Granulocyte colony-stimulating factor-induced isolated hyperbilirubinemia in acute myelogenous leukemia: A case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Jawad K.","family":"Zrein","sequence":"first","affiliation":[{"name":"Department of Hematology-Oncology, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon"},{"name":"Division of Hematology and Oncology, Mount Lebanon Hospital University Medical Center, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3876-3748","authenticated-orcid":false,"given":"Doha A.","family":"Houcheimy","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad S.","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon"},{"name":"Division of Hematology and Oncology, Mount Lebanon Hospital University Medical Center, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250928","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1182\/blood-2007-07-097543","article-title":"Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.","volume":"111","author":"Anderlini","year":"2008","journal-title":"Blood"},{"key":"R2-20250928","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.1086\/513857","article-title":"Granulocyte colony-stimulating factor and granulocyte\u2010macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.","volume":"179","author":"Root","year":"1999","journal-title":"J Infect Dis"},{"key":"R3-20250928","first-page":"7","article-title":"A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.","volume":"26","author":"Dale","year":"2018","journal-title":"Support Care Cancer"},{"key":"R4-20250928","doi-asserted-by":"crossref","first-page":"e234584","DOI":"10.1136\/bcr-2020-234584","article-title":"Filgrastim induced thrombocytopenia.","volume":"13","author":"Kango","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R5-20250928","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.31154","article-title":"Recurrent isolated hyperbilirubinemia from drug-induced impaired hepatic bilirubin uptake.","volume":"72","author":"Feng","year":"2020","journal-title":"Hepatology"},{"key":"R6-20250928","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1665-2681(19)30757-4","article-title":"Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis.","volume":"14","author":"Chavez-Tapia","year":"2015","journal-title":"Ann Hepatol"},{"key":"R7-20250928","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/pharmaceutics12080755","article-title":"Prediction of drug-induced hyperbilirubinemia by in vitro testing.","volume":"12","author":"T\u00e1trai","year":"2020","journal-title":"Pharmaceutics"},{"key":"R8-20250928","doi-asserted-by":"crossref","first-page":"1347395","DOI":"10.3389\/fcell.2024.1347395","article-title":"G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLF.","volume":"12","author":"Ortega-Ribera","year":"2024","journal-title":"Front Cell Dev Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:02:46Z","timestamp":1759046566000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":8,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044637","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2025-02-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}